183
Participants
Start Date
February 6, 2013
Primary Completion Date
October 20, 2015
Study Completion Date
December 10, 2015
GDC-0941
GDC-0941 will be administered QD orally for 5 consecutive days each week.
Placebo
Placebo matching to GDC-0941
Paclitaxel
Paclitaxel will be administered IV weekly for 3 out of 4 weeks in every 28-day cycle.
Institut Jules Bordet, Brussels
Krankenhaus Hietzing m.Neurolog. Zentrum Rosenhuegel, Vienna
Royal Prince Alfred Hospital, Camperdown
Sydney Haematology & Oncology Clinic, Wahroonga
Concord Repatriation General Hospital, Concord
Calvary Mater Newcastle; Medical Oncology, Waratah
Port Macquarie Base Hospital;North Coast Cancer Institute, Port Macquarie
Sint Augustinus Wilrijk, Wilrijk
UZ Antwerpen, Edegem
UZ Leuven Gasthuisberg, Leuven
Peninsula and South Eastern Haematology and Oncology Grou, Frankston
Bendigo Hospital; Oncology, Bendigo
Border Medical Oncology, Wodonga
Royal Brisbane and Women's Hospital, Herston
Klinikum Wels-Grieskirchen, Wels
Mater Adult Hospital, Mackay
Clinique Ste-Elisabeth, Namur
LKH - Universitätsklinikum der PMU Salzburg, Salzburg
Ashford Cancer Center Research, Kurralta Park
Royal Perth Hospital; Medical Oncology, Perth
Royal Hobart Hospital, Hobart
CHU Ambroise Paré, Mons
Lkh-Univ. Klinikum Graz, Graz
ProHEALTH Care Associates LLP, Lake Success
Abington Memorial Hospital, Abington
Shenandoah Oncology Associates, Winchester
Complejo Hospitalario de Jaen, Jaén
Hospital General Univ. Gregorio Maranon, Madrid
START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid
Chungbuk National University Hospital, Cheongju-si
Hematology and Oncology Associates of Sc, Greenville
Phoebe Putney Memorial Hospital, Albany
Cancer Specialists of North Florida, Orange Park
Clinical Research of South Florida, Coral Gables
Hematology - Oncology Associates of Treasure Coast, Port Saint Lucie
Summa Health System, Akron
Aultman Hospital; Aultman Hospital Cancer Center, Canton
TriHealth Oncology Institute, Cincinnati
Henry Ford Health System, Detroit
Oncology Specialists, S.C., Park Ridge
Joliet Oncology-Hematology; Associates, Ltd., Joliet
Illinois Cancer Care, Peoria
Cotton-O'Neil Clinical Research Center, Hematology and Oncology; Cotton O'Neil Cancer Center, Topeka
Nebraska Cancer Specialists; Oncology Hematology West, PC, Omaha
Metairie Oncologist, LLC, Metairie
Hematology Oncology Clinic, Baton Rouge
Texas Oncology, Bedford
Texas Oncology - Memorial City, Houston
Shivers Cancer Center at University Medical Center Brackenridge, Austin
Texas Oncology, P.A. - El Paso; West, El Paso
Northern Utah Associates, Ogden
Arizona Oncology Associates, PC - NAHOA, Sedona
California Cancer Associates for Research & Excellence, Inc., Encinitas
Pacific Cancer Medical Center, Anaheim
Kaiser Permanente - South San Francisco, South San Francisco
Kaiser Permanente - San Francisco (2238 Geary), San Francisco
University of California at San Francisco, San Francisco
Bay Area Cancer Research Group, LLC, Pleasant Hill
Kaiser Permanente - Hayward, Hayward
Kaiser Permanente - Vallejo, Vallejo
Kaiser Permanente - Walnut Creek, Walnut Creek
Kaiser Permanente - Oakland, Oakland
Kaiser Permanente - Santa Clara, Santa Clara
Kaiser Permanente - San Jose, San Jose
Kaiser Permanente Medical Center - Roseville, Roseville
Kaiser Permanente Sacramento Medical Center, Sacramento
Puget Sound Cancer Centers, Edmonds
Swedish Health Services, Seattle
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research, Hartford
Maine Research Associates, Auburn
Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Med Ctr, Brookline
Billings Clinic Cancer Center-CCD PRIME, Billings
Texas Oncology, P.A. ;Sherman Cancer Center, Sherman
Fakultni nemocnice Brno, Brno
Masarykuv onkologicky ustav, Brno
Krajska nemocnice Liberec a.s., Liberec
Multiscan s.r.o., Pardubice
Vseobecna fakultni nemocnice v Praze, Prague
Nemocnice Na Bulovce, Prague
Thomayerova nemocnice, Praha 4 - Krc
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Institut Catala d´Oncologia Hospital Germans Trias i Pujol, Badalona
Institut Catala d Oncologia Hospital Duran i Reynals, Barcelona
Royal Sussex County Hospital, Brighton
Royal Surrey County Hospital, Guildford
Leicester Royal Infirmary, Leicester
Barts Hospital, London
The Christie, Manchester
Freeman Hospital, Newcastle upon Tyne
Nottingham University Hospitals City Campus, Nottingham
Royal Stoke University Hospital, Stoke-on-Trent
Royal Cornwall Hospital, Truro
New Cross Hospital, Wolverhampton
Lead Sponsor
Genentech, Inc.
INDUSTRY